More tools:Markets·Screener·Research·Chat

Maravai LifeSciences Holdings, Inc. Class A Common Stock (MRVI) Financial Statements

Maravai LifeSciences Holdings, Inc. Class A Common Stock
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG00Y1DFW44
XNAS · usd
7.10▼ 0.09 (-1.25%)
As of 2026-09-09
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close7.19
Day's Range7.10 – 7.32
52-Week Range2.42 – 9.42
Volume2.3M
Avg Volume3.8M
Share Statistics
Shares Outstanding
Employees435
ExchangeXNAS
Listed2020-11-20
Share count as of July 31, 2026
Loading Income Statement…
Key questions about Maravai LifeSciences Holdings, Inc. Class A Common Stock (MRVI)
What is Maravai LifeSciences Holdings, Inc. Class A Common Stock's Market Cap?
Maravai LifeSciences Holdings, Inc. Class A Common Stock's Market Cap is $1.8B, based on as-reported figures from SEC (XBRL) filings.
What is Maravai LifeSciences Holdings, Inc. Class A Common Stock's Enterprise Value?
Maravai LifeSciences Holdings, Inc. Class A Common Stock's Enterprise Value is $2.0B, based on as-reported figures from SEC (XBRL) filings.
What is Maravai LifeSciences Holdings, Inc. Class A Common Stock's Price / Sales?
Maravai LifeSciences Holdings, Inc. Class A Common Stock's Price / Sales is 8.8×, based on as-reported figures from SEC (XBRL) filings.
What is Maravai LifeSciences Holdings, Inc. Class A Common Stock's EV / Revenue?
Maravai LifeSciences Holdings, Inc. Class A Common Stock's EV / Revenue is 9.3×, based on as-reported figures from SEC (XBRL) filings.
What is Maravai LifeSciences Holdings, Inc. Class A Common Stock's EV / EBITDA?
Maravai LifeSciences Holdings, Inc. Class A Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Maravai LifeSciences Holdings, Inc. Class A Common Stock's Revenue (TTM)?
Maravai LifeSciences Holdings, Inc. Class A Common Stock's Revenue (TTM) is $208.8M, based on as-reported figures from SEC (XBRL) filings.
What is Maravai LifeSciences Holdings, Inc. Class A Common Stock's Net Income (TTM)?
Maravai LifeSciences Holdings, Inc. Class A Common Stock's Net Income (TTM) is -$77.4M, based on as-reported figures from SEC (XBRL) filings.
What is Maravai LifeSciences Holdings, Inc. Class A Common Stock's EBITDA?
Maravai LifeSciences Holdings, Inc. Class A Common Stock's EBITDA is -$68.3M, based on as-reported figures from SEC (XBRL) filings.
What is Maravai LifeSciences Holdings, Inc. Class A Common Stock's Diluted EPS (TTM)?
Maravai LifeSciences Holdings, Inc. Class A Common Stock's Diluted EPS (TTM) is -0.30, based on as-reported figures from SEC (XBRL) filings.
What is Maravai LifeSciences Holdings, Inc. Class A Common Stock's EBITDA Margin?
Maravai LifeSciences Holdings, Inc. Class A Common Stock's EBITDA Margin is -32.7%, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenue
YoY growth+8.5%+40.5%-11.8%-39.7%
Cost of revenue
Gross profit
% of revenue40.1%51.2%25.8%13.6%
Operating expenses:
Selling, general and administrative
Research and development
Goodwill impairment—
Restructuring
Total operating expenses
% of revenue69.5%54.5%143.7%112.1%
Loss from operations
% of revenue-29.3%-3.3%-117.9%-98.6%
Other income (expense):
Interest expense
Interest income
Loss on extinguishment of debt———
Other expense
Loss before income taxes
Income tax benefit
Net loss
% of revenue-42.0%-9.7%-126.4%-108.2%
Net loss attributable to non-controlling interests
Net loss attributable to Maravai LifeSciences Holdings, Inc.
% of revenue-24.1%-5.7%-71.6%-61.4%
Net loss per Class A common share attributable to Maravai LifeSciences Holdings, Inc., basic (in usd per share)
Net loss per Class A common share attributable to Maravai LifeSciences Holdings, Inc., diluted (in usd per share)